The market capitalization for Quest Diagnostics Incorporated (DGX) is $23.08 Billion, making it a Large Cap company. Market cap is calculated by multiplying the current stock price by the total number of shares outstanding.
Market Capitalization
$23.08B
$23.08 Billion
Calculation
- Stock Price
- $206.24
- Shares Outstanding
- 111.93M
- Market Cap
- $23.08B
Market Cap = Price × Shares Outstanding
Size Classification
Large Cap
$10B - $1T
Companies with market capitalization between $10 billion and $1 trillion.
Market Cap Size Scale
Micro Cap
<$250M
Small Cap
$250M-$2B
Mid Cap
$2B-$10B
Large Cap
$10B-$1T
Mega Cap
>$1T
Related Valuation Metrics
Key Statistics
| Market Cap | $23.08 Billion |
| Stock Price | $206.24 |
| Shares Outstanding | 111.93M |
| Size Category | Large Cap |
| P/E Ratio | 22.79 |
| P/B Ratio | 3.14 |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis